1. 326 Effects of local laser treatment on vulvovaginal atrophy for women with breast cancer: a prospective study with long-term follow-up. (4th December 2020) Authors: Veron, Lucie; Wehrer, Delphine; Annerose-Zephir, Gisèle; Chaltiel, Dan; Delaloge, Suzette; Pistilli, Barbara; Pautier, Patricia Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). (November 2021) Authors: Campone, Mario; Bachelot, Thomas; Treilleux, Isabelle; Pistilli, Barbara; Salleron, Julia; Seegers, Valérie; Arnedos, Monica; Loussouarn, Delphine; Wang, Qing; Vanlemmens, Laurence; Jimenez, Marta; Rios, Maria; Diéras, Véronique; Leroux, Agnès; Paintaud, Gilles; Rezai, Keyvan; André, Fabrice; Lio... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer. (December 2022) Authors: Rassy, Elie; Rached, Layal; Pistilli, Barbara Journal: Breast Issue: Volume 66(2022) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study. (September 2019) Authors: Le Saux, Olivia; Lardy-Cleaud, Audrey; Frank, Sophie; Debled, Marc; Cottu, Paul H.; Pistilli, Barbara; Vanlemmens, Laurence; Leheurteur, Marianne; Lévy, Christelle; Laborde, Lilian; Uwer, Lionel; D'hondt, Veronique; Berchery, Delphine; Lorgis, Veronique; Ferrero, Jean-Marc; Perrocheau, Genevieve;... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. (November 2018) Authors: Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortés, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le... Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2017) Authors: Baselga, José; Im, Seock-Ah; Iwata, Hiroji; Cortés, Javier; De Laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Taka... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cardiotoxicity Related to Long‐Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors. Issue 3 (19th March 2015) Authors: Pistilli, Barbara; Marcellusi, Andrea; Latini, Luciano; Accardi, Roberto; Ferretti, Benedetta; Benedetti, Giovanni Journal: Breast journal Issue: Volume 21:Issue 3(2015:May/Jun.) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer. (2nd January 2019) Authors: Loi, Mauro; Dunant, Ariane; Ghith, Sahar; Cascales-Garcia, Almudena Maria; Mazouni, Chafika; Pistilli, Barbara; Mathieu, Marie-Christine; Deutsch, Eric; Arriagada, Rodrigo; Rivera, Sofia Journal: Cancer investigation Issue: Volume 37:Number 1(2019) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer. Issue 19 (1st August 2022) Authors: Soldato, Davide; Havas, Julie; Crane, Tracy E.; Presti, Daniele; Lapidari, Pietro; Rassy, Nathalie; Pistilli, Barbara; Martin, Elise; Del Mastro, Lucia; Martin, Anne‐Laure; Jacquet, Alexandra; Coutant, Charles; Cottu, Paul; Merimeche, Asma; Lerebours, Florence; Tredan, Olivier; Vanlemmens, Lauren... Journal: Cancer Issue: Volume 128:Issue 19(2022) Page Start: 3552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cognitive change in breast cancer patients up to 2 years after diagnosis. (26th December 2022) Authors: Lange, Marie; Lefevre Arbogast, Sophie; Hardy-Léger, Isabelle; Rigal, Olivier; Le Fel, Johan; Pistilli, Barbara; Petrucci, Jean; Lévy, Christelle; Capel, Aurélie; Coutant, Charles; Médeau, Laure; Lerebours, Florence; Vanlemmens, Laurence; Brion, Marine; Bourbouloux, Emmanuelle; Blain, Maxime; Bin... Journal: Journal of the National Cancer Institute Issue: Volume 115:Number 3(2023) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗